GlaxoSmithKline PLC (NYSE:GSK)

41.02
BATS BZX Real-Time Price
As of 2:01pm ET
 -0.02 / -0.05%
Today’s Change
34.52
Today|||52-Week Range
44.45
+15.65%
Year-to-Date
Large Cap Pharma Stock Outlook: Short-Term Struggle Likely
Jun 18 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Nod for 2nd Lymphoma Indication
Jun 14 / Zacks.com - Paid Partner Content
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III
Jun 15 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Chevron, Glaxo, T-Mobile, Delta Air Lines and Amer...
Jun 14 / Zacks.com - Paid Partner Content
Company News For Jun 15, 2018
Jun 15 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer
Jun 13 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals
Jun 15 / Zacks.com - Paid Partner Content
Top Stock Reports for Chevron, Glaxo & T-Mobile
Jun 13 / Zacks.com - Paid Partner Content
Mylan (MYL) to Get CRL Again for Generic Advair from FDA
Jun 14 / Zacks.com - Paid Partner Content
Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus
Jun 07 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.04
Today’s open41.28
Day’s range40.80 - 41.28
Volume210,520
Average volume (3 months)2,838,732
Market cap$99.3B
Data as of 2:01pm ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)+59.84%
Earnings growth (this year)-2.39%
Earnings growth (next 5 years)+3.22%
Revenue growth (last year)+3.58%
P/E ratio74.7
Price/Sales2.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.45+0.84%
NVONovo Nordisk+0.29+0.65%
CELGCelgene+0.05+0.06%
ABTAbbott Laboratories+0.03+0.05%
Data as of 2:01pm ET, 06/20/2018

Financials

Next reporting dateJuly 25, 2018
EPS forecast (this quarter)$0.72
Annual revenue (last year)$38.9B
Annual profit (last year)$2.0B
Net profit margin5.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Paul Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts